March, 5th, 2019

WHIPgroup obtained issuance of U.S. Patent No. 10,143,555 for its client Oxford Performance Materials, Inc. for Customized Implants for Bone Replacement after the examiner initially rejected claims as being anticipated or obvious over other references.  The patent covers the clients OSTEOFAB® implants which are produced from polyetherketoneketone (PEKK) using a proprietary 3D printing process. In one commercial use, the OsteoFab® Patient Specific Cranial Device (OPSCD) is intended for the replacement of bony voids in the cranial skeleton. The OPSCD is constructed with the use of the patient’s CT imaging data and computer aided design to determine the dimensions of each implant. The device is then manufactured via the OsteoFab® 3D printing laser sintering process. The OPSCD is attached to native bone with commercially available cranioplasty fixation systems and is a non-load bearing, single use device that is sterilized at the healthcare facility using validated steam sterilization cycles.

© Copyright 2019 Whitmyer IP Group